Williams Ryan, Ostinelli Edoardo G, Agorinya Joel, Minichino Amedeo, De Crescenzo Franco, Maughan Daniel, Puntis Stephen, Cliffe Charlotte, Kurtulmus Ayse, Lennox Belinda R, Cipriani Andrea
Department of Brain Sciences, Imperial College London, London, UK.
South London & Maudsley NHS Foundation Trust, Maudsley Hospital, London, UK.
EClinicalMedicine. 2024 Mar 14;70:102537. doi: 10.1016/j.eclinm.2024.102537. eCollection 2024 Apr.
'Early Intervention in Psychosis' (EIP) services have been associated with improved outcomes for early psychosis. However, these services are heterogeneous and many provide different components of treatment. The impact of this variation on the sustained treatment effects is unknown.
We performed a systematic review and component network meta-analysis (cNMA) of randomised controlled trials (RCTs) that compared specialised intervention services for early psychosis. We searched CENTRAL (published and unpublished), EMBASE, MEDLINE, CINAHL, PsycINFO and Web of Science from inception to February 2023. Primary outcomes were negative and positive psychotic symptoms at 3-month and 1-year follow-up and treatment dropouts. Secondary outcomes were depressive symptoms and social functioning at 1-year follow-up. We registered a protocol for our study in PROSPERO (CRD42017057420).
We identified 37 RCTs including 4599 participants. Participants' mean age was 25.8 years (SD 6.0) and 64.0% were men. We found evidence that psychological interventions (this component grouped all psychological treatment intended to treat, or ameliorate the consequences of, psychotic symptoms) are beneficial for reducing negative symptoms (iSMD -0.24, 95% CI -0.44 to -0.05, p = 0.014) at 3-month follow-up and may be associated with clinically relevant benefits in improving social functioning scores at 1-year follow-up (iSMD -0.52, 95% CI -1.05 to 0.01, p = 0.052). The addition of case management has a beneficial effect on reducing negative symptoms (iSMD -1.17, 95% CI -2.24 to -0.11, p = 0.030) and positive symptoms (iSMD -1.05, 95% CI -2.02 to -0.08, p = 0.033) at 1-year follow-up. Pharmacotherapy was present in all trial arms, meaning it was not possible to examine the specific effects of this component.
Our findings suggest psychological interventions and case management in addition to pharmacotherapy as the core components of services for early psychosis to achieve sustained clinical benefits. Our conclusions are limited by the small number of studies and sparsely connected networks.
National Institute for Health and Care Research.
“精神病早期干预”(EIP)服务与早期精神病患者改善的治疗结果相关。然而,这些服务存在异质性,许多服务提供不同的治疗组成部分。这种差异对持续治疗效果的影响尚不清楚。
我们对比较早期精神病专门干预服务的随机对照试验(RCT)进行了系统评价和成分网络荟萃分析(cNMA)。我们检索了CENTRAL(已发表和未发表)、EMBASE、MEDLINE、CINAHL、PsycINFO和Web of Science数据库,检索时间从建库至2023年2月。主要结局是3个月和1年随访时的阴性和阳性精神病性症状以及治疗退出率。次要结局是1年随访时的抑郁症状和社会功能。我们在PROSPERO(CRD42017057420)中注册了本研究的方案。
我们纳入了37项RCT,共4599名参与者。参与者的平均年龄为25.8岁(标准差6.0),64.0%为男性。我们发现有证据表明,心理干预(该成分包括所有旨在治疗或改善精神病性症状后果的心理治疗)有利于在3个月随访时减轻阴性症状(标准化均差-0.24,95%可信区间-0.44至-0.05,p=0.014),并且可能与1年随访时改善社会功能评分的临床相关益处有关(标准化均差-0.52,95%可信区间-1.05至0.01,p=0.052)。在1年随访时,增加个案管理对减轻阴性症状(标准化均差-1.17,95%可信区间-2.24至-0.11,p=0.030)和阳性症状(标准化均差-1.05,95%可信区间-2.02至-0.08,p=0.033)有有益作用。所有试验组均采用了药物治疗,这意味着无法检验该成分的具体效果。
我们的研究结果表明,除药物治疗外,心理干预和个案管理作为早期精神病服务的核心组成部分,可实现持续的临床益处。我们的结论受研究数量少和网络连接稀疏的限制。
英国国家卫生与保健研究院。